Search Results
Sep 07, 2026, 13:22 ET Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline
you have until September 28, 2026, to ask the court to appoint you as lead plaintiff. You do not need to seek lead plaintiff status to share in any potential recovery.To learn more about your legal options,
More news about: Hagens Berman Sobol Shapiro LLP
Sep 07, 2026, 13:20 ET Wix.com (WIX) Faces Securities Class Action Amid Scrutiny Over Vibe Coding Transition, Competitive and Financial Positioning - Hagens Berman
the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email
More news about: Hagens Berman Sobol Shapiro LLP
Sep 07, 2026, 13:19 ET INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026
the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email
More news about: Hagens Berman Sobol Shapiro LLP
Sep 07, 2026, 13:19 ET Cogent Communications Holdings Securities Fraud Class Action Result of Undisclosed Demand and Backlog Issues and approximately 29% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP
the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email
More news about: Hagens Berman Sobol Shapiro LLP
Sep 07, 2026, 13:19 ET REGN 1-WEEK DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit
the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email
More news about: Hagens Berman Sobol Shapiro LLP
Sep 07, 2026, 12:30 ET Wise Group plc (WSE) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
investors suffered damages.Contact Us To Participate or Learn More: If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact: Howard
More news about: Law Offices of Howard G. Smith
Sep 07, 2026, 12:00 ET Bronstein, Gewirtz & Grossman LLC Urges Papa John's International, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
you suffered a loss in Papa John's you have until November 2, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.No Cost to Papa John's InvestorsWe, Bronstein, Gewirtz & Grossman
More news about: Bronstein, Gewirtz & Grossman, LLC
Sep 07, 2026, 12:00 ET Sony Electronics Introduces WH-1000XM4C (M4 2nd Gen) Wireless Noise-Cancelling Headphones and Updates Popular Mid- and Entry-Level Wireless Headphones with WH-CH730N and WH-CH530
foldable design, improved call quality, and longer battery life from its predecessor. WH-CH530 is available in six playful colors to match any style, combines lightweight comfort, longer battery life, and improved call quality for everyday wireless listening.SAN
More news about: Sony Electronics, Inc.
Sep 07, 2026, 10:05 ET Summary Notice to Stockholders of Supernova Partners Acquisition Company, Inc. as of August 27, 2021
in what amount any service award should be paid to Plaintiff (up to a requested amount of $3,000) to Plaintiff, to be paid exclusively out of the Fee and Expense Award; and (x) consider any other matters that may properly be brought before the Court in connection with the Settlement. Any updates regarding
More news about: Levi & Korsinsky, LLP
Sep 07, 2026, 09:59 ET Notice Convening an Extraordinary General Meeting of AB SKF
of Directors and the President shall, upon request by any shareholder and where the Board of Directors believes that it may take place without significant harm to the company, at the Extraordinary General Meeting provide information in respect of any circumstances which may affect the assessment of a matter
More news about: SKF
Sep 07, 2026, 09:54 ET Notice Convening an Extraordinary General Meeting of AB SKF
of Directors and the President shall, upon request by any shareholder and where the Board of Directors believes that it may take place without significant harm to the company, at the Extraordinary General Meeting provide information in respect of any circumstances which may affect the assessment of a matter
More news about: SKF
Sep 07, 2026, 09:00 ET CART Blood Pressure Monitor Demonstrates Utility in BP Monitoring for AF and Heart Failure Patients
Disclaimer: CART blood pressure monitor is a prescription-only medical device intended for use under the guidance of a healthcare professional. Any adjustments to medication or treatment plans must be made in consultation with a qualified healthcare provider.
More news about: Sky Labs
Sep 07, 2026, 09:00 ET Cognizant Invests in America's AI-Era Workforce
manager each week. That workforce is being built on the leading frontier AI platforms: Cognizant holds more than 15,000 Claude certifications, the most of any Anthropic partner globally, and 5,000 Codex certifications as one of a small group of global OpenAI Codex partners, while Google Cloud is expanding its
More news about: Cognizant Technology Solutions Corporation
Sep 07, 2026, 08:30 ET U.S. District Court Invalidates Kaneka's Ubiquinol Patent, Clearing the Way for Cocrystal Tech's CrysQnol™ in the U.S. Market
marketed as CrysQnol™ - infringed U.S. Patent No. 7,829,080 (the "'080 Patent"). The asserted claims cover compositions of reduced coenzyme Q10 containing any amount of reduced coenzyme Q11, a naturally occurring minor component found in CoQ10 materials. Although Cocrystal Tech stipulated that its product fell
More news about: Cocrystal Technology (Jiaxing) Co., Ltd.
Sep 07, 2026, 03:00 ET YPF Sociedad Anónima Announces Commencement of Tender Offers for up to U.S.$500,000,000 Maximum Purchase Price of Outstanding Securities of the Series Listed Below, subject to the Priorities Set Forth Herein
trustee for the Securities, or any of their respective affiliates, is making any recommendation as to whether Holders should or should not tender any Securities in response to the Tender Offers or expressing any opinion as to whether the terms of the Tender Offers are fair to any holder. Holders must make
More news about: YPF Sociedad Anónima
Sep 07, 2026, 03:00 ET CART Blood Pressure Monitor Demonstrates Utility in BP Monitoring for AF and Heart Failure Patients
[email protected]: CART blood pressure monitor is a prescription-only medical device intended for use under the guidance of a healthcare professional. Any adjustments to medication or treatment plans must be made in consultation with a qualified healthcare provider.
More news about: Sky Labs
Sep 07, 2026, 02:10 ET ACG to Acquire Keşkek Licence to Extend Gold Production
and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements. Factors that may cause actual results to differ materially
More news about: ACG METALS LIMITED
Sep 07, 2026, 02:02 ET Multiconsult and Rejlers to create a leading pan-Nordic multidisciplinary consultancy group through a merger of equals
MULTICONSULT AND REJLERSMulticonsult does not hold or control any shares in Rejlers or any other financial instruments, which give Multiconsult a financial exposure equivalent to a shareholding in Rejlers. Multiconsult has not acquired any shares in Rejlers during the last six months prior to the announcement
More news about: Multiconsult
Sep 07, 2026, 01:58 ET Multiconsult and Rejlers to create a leading pan-Nordic multidisciplinary consultancy group through a merger of equals
MULTICONSULT AND REJLERSMulticonsult does not hold or control any shares in Rejlers or any other financial instruments, which give Multiconsult a financial exposure equivalent to a shareholding in Rejlers. Multiconsult has not acquired any shares in Rejlers during the last six months prior to the announcement
More news about: Multiconsult
Sep 07, 2026, 01:14 ET Prof Kevin Plaxco joins Nutromics as Chief Scientific Officer, bolstering expansion efforts for the DNA-based sensing platform
first product, with operations in Australia and the United States. This product is currently in development and has not yet been approved by the FDA, or any regulatory body. The company's vision is a world with zero preventable deaths due to a lack of continuous molecular monitoring.
More news about: Nutromics
Sep 06, 2026, 20:58 ET Baidu Announces Inclusion of Its Class A Ordinary Shares in the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect Programs
with the Securities and Exchange Commission, and announcements on the website of the Hong Kong Stock Exchange. Baidu does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release and in the attachments
More news about: Baidu, Inc.
Sep 06, 2026, 19:07 ET Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults
of historical fact nor guarantees or assurances of future performance. We caution you therefore against placing undue reliance on any of these forward-looking statements. Any forward-looking statement made by us in this document speaks only as of the date on which it is made. Factors or events that could
More news about: Clover Biopharma
Sep 06, 2026, 18:08 ET WSE Deadline: WSE Investors with Losses in Excess of $100K Have Opportunity to Lead Wise Group plc Securities Fraud Lawsuit Filed by The Rosen Law Firm
by the Firm.So what: If you purchased Wise Group plc securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Wise Group plc class action, go to
More news about: THE ROSEN LAW FIRM, P. A.
Sep 06, 2026, 17:59 ET AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit
important October 13, 2026 lead plaintiff deadline.So what: If you purchased Aardvark securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Aardvark class action, go to
More news about: THE ROSEN LAW FIRM, P. A.
Sep 06, 2026, 12:00 ET Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
917-590-0911. If you suffered a loss in Hims you have until November 1, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.No Cost to Hims InvestorsWe, Bronstein, Gewirtz & Grossman LLC, represent
More news about: Bronstein, Gewirtz & Grossman, LLC